NGL Fine-Chem Ltd

NGLFINE

Company Profile

  • Business description

    NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.

  • Contact

    301, E Square, Subhash Road
    Vile Parle (East)
    MumbaiMH400057
    IND

    T: +91 2240842222

    https://www.nglfinechem.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2026

    Employees

    523

Stocks News & Analysis

stocks

Picking dividend shares in 2026? Here’s where to look

A new report from Morningstar shows opportunities for income investors.
stocks

Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?

With outstanding long-term estimates, here’s what we think of Nvidia stock.
stocks

Wide moat ASX listed global leader keeps winning

Latest earnings show continued strength.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,747.505.80-0.07%
CAC 407,967.93151.09-1.86%
DAX 4023,180.53409.99-1.74%
Dow JONES (US)46,091.74498.50-1.07%
FTSE 1009,552.30123.13-1.27%
HKSE25,931.281.250.00%
NASDAQ22,432.85275.23-1.21%
Nikkei 22548,989.05286.070.59%
NZX 50 Index13,317.4125.41-0.19%
S&P 5006,617.3255.09-0.83%
S&P/ASX 2008,473.4010.10-0.12%
SSE Composite Index3,946.466.650.17%

Market Movers